Adrenaline for the pharmacological treatment of cardiac arrest… going, going, gone?

      The use of vasopressors in large doses has been one of the cornerstones of the management of cardiac arrest for half a century. Extensive research has been conducted into the effects of various vasopressors, including adrenaline (epinephrine) and vasopressin, on a variety of different outcome measures: return of spontaneous circulation (ROSC), survival to hospital, survival to discharge, and survival with favourable neurological outcome.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Resuscitation
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Larabee T.M.
        • Liu K.Y.
        • Campbell J.A.
        • Little C.M.
        Vasopressors in cardiac arrest: a systematic review.
        Resuscitation. 2012; 83: 932-939
        • Morley P.T.
        • Atkins D.L.
        • Billi J.E.
        • et al.
        Part 3: Evidence evaluation process: 2010 international consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment Recommendations.
        Resuscitation. 2010; 81: e32-e40
        • Olasveengen T.M.
        • Sunde K.
        • Brunborg C.
        • Thowsen J.
        • Steen P.A.
        • Wik L.
        Intravenous drug administration during out-of-hospital cardiac arrest: a randomized trial.
        JAMA. 2009; 302: 2222-2229
        • Jacobs I.G.
        • Finn J.C.
        • Jelinek G.A.
        • Oxer H.F.
        • Thompson P.L.
        Effect of adrenaline on survival in out-of-hospital cardiac arrest: a randomised double-blind placebo-controlled trial.
        Resuscitation. 2011; 82: 1138-1143
        • Woodhouse S.P.
        • Cox S.
        • Boyd P.
        • Case C.
        • Weber M.
        High dose and standard dose adrenaline do not alter survival, compared with placebo, in cardiac arrest.
        Resuscitation. 1995; 30: 243-249
        • Herlitz J.
        • Ekstrom L.
        • Wennerblom B.
        • Axelsson A.
        • Bang A.
        • Holmberg S.
        Adrenaline in out-of-hospital ventricular fibrillation. Does it make any difference?.
        Resuscitation. 1995; 29: 195-201
        • Ong M.E.
        • Tan E.H.
        • Ng F.S.
        • et al.
        Survival outcomes with the introduction of intravenous epinephrine in the management of out-of-hospital cardiac arrest.
        Ann Emerg Med. 2007; 50: 635-642
        • Ong M.E.
        • Tiah L.
        • Leong B.S.
        • et al.
        A randomised, double-blind, multi-centre trial comparing vasopressin and adrenaline in patients with cardiac arrest presenting to or in the Emergency Department.
        Resuscitation. 2012; 83: 953-960
        • Kreutziger J.
        • Wenzel V.
        Shape and size of cardiopulmonary resuscitation trials to optimise impact of advanced life support interventions.
        Resuscitation. 2012; 83: 923-924
        • Olasveengen T.M.
        • Wik L.
        • Sunde K.
        • Steen P.A.
        Outcome when adrenaline (epinephrine) was actually given vs. not given – post hoc analysis of a randomized clinical trial.
        Resuscitation. 2012; 83: 327-332
        • Hayashi Y.
        • Iwami T.
        • Kitamura T.
        • et al.
        Impact of early intravenous epinephrine administration on outcomes following out-of-hospital cardiac arrest.
        Circ J. 2012;
        • Hagihara A.
        • Hasegawa M.
        • Abe T.
        • Nagata T.
        • Wakata Y.
        • Miyazaki S.
        Prehospital epinephrine use and survival among patients with out-of-hospital cardiac arrest.
        JAMA. 2012; 307: 1161-1168
        • Nordseth T.
        • Olasveengen T.M.
        • Kvaloy J.T.
        • Wik L.
        • Steen P.A.
        • Skogvoll E.
        Dynamic effects of adrenaline (epinephrine) in out-of-hospital cardiac arrest with initial pulseless electrical activity (PEA).
        Resuscitation. 2012; 83: 946-952
        • Birkenes T.S.
        • Myklebust H.
        • Neset A.
        • Olasveengen T.M.
        • Kramer-Johansen J.
        Video analysis of dispatcher-rescuer teamwork—effects on CPR technique and performance.
        Resuscitation. 2012; 83: 494-499
        • Sun S.
        • Tang W.
        • Song F.
        • et al.
        The effects of epinephrine on outcomes of normothermic and therapeutic hypothermic cardiopulmonary resuscitation.
        Crit Care Med. 2010; 38: 2175-2180
        • Schmittinger C.A.
        • Torgersen C.
        • Luckner G.
        • Schroder D.C.
        • Lorenz I.
        • Dunser M.W.
        Adverse cardiac events during catecholamine vasopressor therapy: a prospective observational study.
        Intensive Care Med. 2012; 38: 950-958
        • Gao Smith F.
        • Perkins G.D.
        • Gates S.
        • et al.
        Effect of intravenous beta-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial.
        Lancet. 2012; 379: 229-235
        • Burnett A.M.
        • Segal N.
        • Salzman J.G.
        • McKnite M.S.
        • Frascone R.J.
        Potential negative effects of epinephrine on carotid blood flow and ETCO(2) during active compression-decompression CPR utilizing an impedance threshold device.
        Resuscitation. 2012; 83: 1021-1024
        • Ristagno G.
        • Tang W.
        • Huang L.
        • et al.
        Epinephrine reduces cerebral perfusion during cardiopulmonary resuscitation.
        Crit Care Med. 2009; 37: 1408-1415
        • Olasveengen T.M.
        Can drugs ever improve outcome after cardiac arrest.
        Resuscitation. 2012; 83: 663-664
        • de Oliveira F.C.
        • Feitosa-Filho G.S.
        • Ritt L.E.
        Use of beta-blockers for the treatment of cardiac arrest due to ventricular fibrillation/pulseless ventricular tachycardia: a systematic review.
        Resuscitation. 2012; 83: 674-683